Evidence map›Paper›PMID 9500789›Full record

ArticleThe Journal of experimental medicine1998

Physical and functional association of the major histocompatibility complex class I heavy chain alpha3 domain with the transporter associated with antigen processing.

K Kulig, D Nandi, I Bacik, J J Monaco, S Vukmanović

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of experimental medicine, 1998. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
2.9field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 45 citations in OpenAlex.

  1. Article
  2. The binding of TAPBPR and Tapasin to MHC class I is mutually exclusive.Journal of immunology (Baltimore, Md. : 1950) · 2013
    Article
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 3 countries.

K KuligMichael Heidelberger Division of Immunology, the Department of Pathology and Kaplan Comprehensive Cancer Center, New York University Medical Center, New York 10016, USA.
D Nandi
I Bacik
J J Monaco
S Vukmanović
University of Cincinnati · USHeidelberg University · DEHoward Hughes Medical Institute · USIndian Institute of Science Bangalore · IN

Funding

Vaccine FacilityP30CA016087 · NCI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI Drew R Jones · 1985 to 2026
$83.1M
ROLE OF THE PROTEASOME/LMP COMPLEX IN ANTIGEN PROCESSINGR01AI033605 · NIAID · VIRGINIA COMMONWEALTH UNIVERSITY · PI MONACO, JOHN J. · 1993 to 1997
–
NCI NIH HHS 5P30 CA-16087NCI NIH HHS P30 CA016087NIAID NIH HHS AI-33605
6 · The paper itself

Abstract

CD8+ T lymphocytes recognize antigens as short, MHC class I-associated peptides derived by processing of cytoplasmic proteins. The transporter associated with antigen processing translocates peptides from the cytosol into the ER lumen, where they bind to the nascent class I molecules. To date, the precise location of the class I-TAP interaction site remains unclear. We provide evidence that this site is contained within the heavy chain alpha3 domain. Substitution of a 15 amino acid portion of the H-2Db alpha3 domain (aa 219-233) with the analogous MHC class II (H-2IAd) beta2 domain region (aa 133-147) results in loss of surface expression which can be partially restored upon incubation at 26 degrees C in the presence of excess peptide and beta2-microglobulin. Mutant H-2Db (Db219-233) associates poorly with the TAP complex, and cannot present endogenously-derived antigenic peptides requiring TAP-dependent translocation to the ER. However, this presentation defect can be overcome through use of an ER targeting sequence which bypasses TAP-dependent peptide translocation. Thus, the alpha3 domain serves as an important site of interaction (directly or indirectly) with the TAP complex and is necessary for TAP-dependent peptide loading and class I surface expression.

Indexed as

Antigen PresentationAmino Acid SequenceAnimalsATP-Binding Cassette TransportersATP Binding Cassette Transporter, Subfamily B, Member 2ATP Binding Cassette Transporter, Subfamily B, Member 3beta 2-MicroglobulinH-2 AntigensHistocompatibility Antigen H-2DMiceMice, Inbred C57BLMolecular Sequence DataMutationStructure-Activity RelationshipT-Lymphocytes, CytotoxicATP-Binding Cassette TransportersATP Binding Cassette Transporter, Subfamily B, Member 2ATP Binding Cassette Transporter, Subfamily B, Member 3beta 2-MicroglobulinH-2 AntigensHistocompatibility Antigen H-2DTAP1 protein, humanTap1 protein, mouseTAP2 protein, humanTap2 protein, mouse

Identifiers

PMID9500789
PMCPMC2212190
OpenAlexW2153877188

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.